Real-world outcomes in patients with KRAS G12C–mutated advanced non-small cell lung cancer treated with docetaxel in second-line or beyond-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world outcomes in patients with KRAS G12C–mutated advanced non-small cell lung cancer treated with docetaxel in second-line or beyond

Published:2023-07 Issue: Volume:181 Page:107260
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Gray Jhanelle E.,Hsu Hil,Younan Diana,Suri Gaurav,Chia Victoria,Spira Alexander,Johnson Melissa

Funder

Amgen

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference46 articles.

1. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed May 17, 2023.

2. American Cancer Society: Cancer Facts & Figures 2022. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2022/2022-cancer-facts-and-figures.pdf. Accessed May 17, 2023.

3. Lung Cancer - Non-Small Cell: Statistics. https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/statistics. Accessed May 17, 2023.

4. The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma;Biernacka;Cancer Genet.,2016

5. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma;Riely;Clin. Cancer Res.,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CodeBreak 200: study limitations, and future directions;Translational Cancer Research;2024-01

2. KRAS G12C-mutant driven non-small cell lung cancer (NSCLC);Critical Reviews in Oncology/Hematology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP